AF
AGIO icon

Amalgamated Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Amalgamated Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$191K Buy
+6,556
New +$200K ﹤0.01% 1913

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Amalgamated Financial's AGIO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2022: 6,556 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #1913 among its holdings.

161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Amalgamated Financial held 6,556 shares of Agios Pharmaceuticals worth $191K as of Q1 2022.
  • Agios Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Agios Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1913 holding.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.